1-Benzylpsilocin and psilocin benzoate
Erspamer, V. (1961) Recent research in the field of 5-hydroxytryptamine and related indolealkylamines In Jucker, E. Fortschritte der Arzneimittelforschung/Progress in drug research (Vol. 3). Basel: Birkhäuser.
[p. 266] “The most interesting of these compounds are: N,N-dimethyltryptarnine, N,N-diethyltryptamine, N,N-dipropyltryptamine, N,N-dibutyltryptamine, N,N-dibutyl-5-methoxytryptamine, N,N-dibutyl-5-HT, 5-methoxy-β-methyl-tryptamine and β-hydroxy-bufotenine. Starting from the observation that psilocin and also psilocybin, like bufotenine and N,N-dimethyltryptamine, show definite antagonistic action towards 5-HT, Cerletti et al. [249]† succeeded in preparing psilocin derivatives which manifest anti-5-HT action [antagonism] **considerably greater than that possessed by the parent substance**. 1-Benzylpsilocin and psilocin benzoate, for example, have 10 and 18%, respectively, of the antagonistic potency of LSD.”
†[249] A. CERLETTI, Atti 2° Simp. Centro Cefalee Firenze 1960, pp. 27-59.
http://books.google.com/books?id=TJr5BwAAQBAJ[Note: I came across this outdated text when I was researching nicotine salts. The benzoate salts of nicotine, currently used in certain brand name e-cigarettes, are claimed in a patent, filed in 2013 (link below), to have a significantly increased drug effect. This description of the benzoate salts of substituted tryptamines presented here are an artifact for historical/trivia interest only (as opposed to any valid scientific/pharmacological value). The claims of psilocin derivatives “which manifest anti-5-HT action considerably greater than that possessed by the parent substance” are not necessarily accurate or even applicable to increased potency—nor is there any specific safety information I could find in regards to “psilocin benzoate”.
That said, **it would be interesting to learn more about the underlying claims of increased activity of benzoate salts in general**.
Nicotine levels in plasma after vaping e-liquid, as discussed in the patent, and central 5-HT2A receptor action by psilocin/-cybin from oral ingestion are not just “apples and oranges”—there should be no direct analogy there (i.e. apples and lightbulbs).]
•United States Patent Application Publication – Bowen et al.
– Pub. No.: US2015/0020824A1
– Pub. Date: Jan. 22, 2015
NICOTINE SALT FORMULATIONS FOR AEROSOL DEVICES AND METHODS THEREOF
Applicant: Ploom, Inc., San Francisco, CA (US) [...]
DETAILED DESCRIPTION OF THE INVENTION: [...] Studies on the transfer efficiency of freebase nicotine and nicotine salts are complex and have yielded unpredictable results. [...]
It has also been unexpectedly discovered herein that certain nicotine salt formulations provide greater satisfaction than other nicotine salt formulations, and such effect has been shown in blood plasma levels of example nicotine salt formulations herein[...]
EXAMPLES: Nicotine benzoate salt formulation: 0.15g benzoic acid was added to a beaker followed by adding 0.2g [freebase] nicotine to the same beaker. The mixture was stirred at 55°C for 20 minutes until benzoic acid was completely dissolved and an orange oily mixture was formed.”
http://bit.ly/2uK8NivShould this information be interpreted in terms of psilocybin mushroom preparation methods? If so, how?
Spellbreaking is the better part of alchemy, extraction, and the art of undoing—but a cocksure kind of lovingkindness, a clockwork clock, works time.
Nakhig lo shulun, Sharuku! Gorz nash!
“Where is your master? Where is he?”
Mig shâ zog... Undagush! Nakh
Atigat iuk no lighav wizard...